Skip to main content

Table 2 Estimated cost inputs used in the model

From: Cost-effectiveness of sorafenib versus SBRT for unresectable advanced hepatocellular carcinoma

Cost input Value
Cost administration and health States
 PFS per course
  Sorafenib SBRT
  Drug or treatment cost 537,264 210,000
  Costs of test: laboratory test, CT 21,000 32,347
  Costs of physician visit, dispensing fee, nursing care 3000 0
  Adverse events treatment 38 16709
Sub-total 563,365 259,056
 PD per visit   
  Costs of test: laboratory test, CT 10,728 10,728
  Costs of physician visit, dispensing fee, nursing care 15,600 15,600
  End of life care 391,200 391,200
Sub-total 417,528 417,528
  1. Abbreviation: PFS progression free survival, PD progression disease, CT computerized tomography, SBRT stereotactic body radiotherapy